Your session is about to expire
← Back to Search
Other
Beef Protein for Vascular Disease
N/A
Waitlist Available
Led By Carl L Keen, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Male or postmenopausal female 55-70 years of age
BMI 18.5 - 29.9 kg/m2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
Study Summary
This trial is testing whether beef can help improve metabolic function and cardiovascular health by increasing zinc absorption into cells.
Eligible Conditions
- Metabolic Diseases
- Vascular Disease
- Inflammation
- Zinc Deficiency
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
Men or women who have gone through menopause and are between 55 and 70 years old.
Select...
Your body mass index (BMI) is between 18.5 and 29.9.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
intracellular zinc status
microvascular function
Secondary outcome measures
plasma fatty acids
plasma lipids
plasma oxylipins
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Beef ProteinExperimental Treatment1 Intervention
A beef stew, providing 8.8 mg zinc, 37.9 mg protein (approximately 500 kcal/d energy);
Group II: Animal ProteinActive Control1 Intervention
A control plant protein stew, providing 8.8 mg zinc, 37.9 mg protein (approximately 500 kcal/d energy);
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
910 Previous Clinical Trials
4,706,985 Total Patients Enrolled
2 Trials studying Metabolic Diseases
68 Patients Enrolled for Metabolic Diseases
National Cattlemen's Beef AssociationOTHER
24 Previous Clinical Trials
1,100 Total Patients Enrolled
Carl L Keen, PhDPrincipal InvestigatorDistinguished Professor Emeritus of Nutrition
15 Previous Clinical Trials
433 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You take daily blood thinners like aspirin or NSAIDs.You regularly do intense exercise.You have kidney or liver disease that you have reported yourself.Men or women who have gone through menopause and are between 55 and 70 years old.You have a history of heart disease, heart attacks, or strokes.You are currently taking certain medications that affect how your body processes zinc, protein, or fat.You use cigarettes, e-cigarettes, or cannabis.You follow a vegan, vegetarian, or non-traditional diet like Atkins, Keto, or Paleo.You eat strawberries 2-3 times a week on a regular basis.You eat at least 4 cups of vegetables every day.You have peripheral artery disease or Raynaud's syndrome.You eat more than 3 cups of fruit per day.You drink three or more cups of coffee or tea per day.You eat more than 3 ounces of dark chocolate per day.Men who drink more than 2 alcoholic drinks a day, and women who drink more than 1 alcoholic drink a day are not eligible.You limit your physical activity because of a long-term health issue.You have been diagnosed with diabetes and you report it yourself.Your blood pressure is higher than 140/90 mm Hg.You cannot correctly put on the PAT probes or had unusual results during the pre-screening PAT test.You have been diagnosed with cancer in the last 5 years.You have trouble absorbing nutrients from food.Your body mass index (BMI) is between 18.5 and 29.9.
Research Study Groups:
This trial has the following groups:- Group 1: Beef Protein
- Group 2: Animal Protein
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any medical patients who would be ineligible for this research?
"Eligible patients for this research should be experiencing inflammation and be within the age range of 55 to 70. This study is looking for approximately 40 participants."
Answered by AI
Are people aged 35 and up being actively recruited for this clinical trial?
"The recruitment drive for this particular trial is focused on individuals who are within the age bracket of 55 to 70 years old."
Answered by AI
Are there any positions still open in this trial for new participants?
"According to clinicaltrials.gov, this trial is not looking for patients at the moment. The trial was originally posted on October 1st, 2020, and the most recent edit was on September 12th, 2020. Even though this study isn't looking for volunteers right now, there are 617 other studies that are."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger